Further hearing loss during osteoporosis treatment with etidronate.

Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yaşil, S., Cömlekçi, A., Güneri, A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Group 1998
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360958/
https://ncbi.nlm.nih.gov/pubmed/9799894
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge